Department of Surgery, Medical Research Institute, Alexandria University, 165 Horreya Avenue, Hadara, 21561, Alexandria, Egypt.
Consultant of Bariatric Surgery at Madina Women's Hospital (IFSO Center of Excellence), Alexandria, Egypt.
Surg Endosc. 2022 Dec;36(12):9146-9155. doi: 10.1007/s00464-022-09395-4. Epub 2022 Jun 28.
Long-term weight regain (WR) after sleeve gastrectomy (SG) is a major challenge. Laparoscopic banded SG (BSG) was introduced to overcome pouch dilation and, consequently, WR; however, its mid-and long-term outcomes have not been sufficiently demonstrated.
This study retrospectively evaluated the mid-term weight loss efficacy and morbidity over at least a 4-year follow-up after laparoscopic banded SG using a MiniMizer Gastric Ring® and laparoscopic non-banded SG.
The data of 1586 bariatric surgeries were retrospectively evaluated. To ensure homogeneity in our study cohort, propensity score matching (PSM) was performed.
The final cohort comprised 1392 patients: the non-banded SG (n = 1260) and BSG (n = 132) groups. In our matched cohort (SG, n = 655 and BSG, n = 132), WR was noted in 4 (3.0%) and 71 (10.8%) patients in the BSG and SG groups, respectively. Gastric band erosion or slippage was not noted in the BSG cohort. The levels of cholesterol and triglyceride were similar in the two groups. Postoperative glycemic control was significantly reduced in the BSG group.
Although the percentage of weight loss achieved in the BSG group was low in the first year postoperatively, the mid-term (sustained) weight loss associated with BSG was superior to that associated with non-banded SG. BSG is a safe procedure with no significant mid-term band-related morbidity; its impact on the resolution of comorbidities is equivalent and perhaps superior to SG.
袖状胃切除术(SG)后长期体重复重(WR)是一个主要挑战。腹腔镜带囊 SG(BSG)的引入是为了克服囊扩张,从而避免 WR;然而,其中期和长期结果尚未得到充分证明。
本研究回顾性评估了使用 MiniMizer Gastric Ring® 和腹腔镜非带囊 SG 进行腹腔镜带囊 SG 后至少 4 年的中期减重效果和发病率。
回顾性评估了 1586 例减肥手术的数据。为了确保我们的研究队列具有同质性,进行了倾向评分匹配(PSM)。
最终队列包括 1392 例患者:非带囊 SG(n=1260)和 BSG(n=132)组。在我们匹配的队列(SG,n=655 和 BSG,n=132)中,BSG 和 SG 组分别有 4(3.0%)和 71(10.8%)例患者出现 WR。BSG 组未发现胃带侵蚀或滑脱。两组的胆固醇和甘油三酯水平相似。BSG 组术后血糖控制显著降低。
尽管 BSG 组术后第一年的减重百分比较低,但 BSG 与非带囊 SG 相比,中期(持续)减重效果更好。BSG 是一种安全的手术,没有明显的中期带相关发病率;其对合并症的影响与 SG 相当,甚至可能更优。